These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17894534)

  • 1. Studies of the human oropharyngeal airspaces using magnetic resonance imaging IV--the oropharyngeal retention effect for four inhalation delivery systems.
    Burnell PK; Asking L; Borgström L; Nichols SC; Olsson B; Prime D; Shrubb I
    J Aerosol Med; 2007; 20(3):269-81. PubMed ID: 17894534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic change of the upper airway during inhalation via aerosol delivery devices.
    Ehtezazi T; Horsfield MA; Barry PW; O'Callaghan C
    J Aerosol Med; 2004; 17(4):325-34. PubMed ID: 15684732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhalation of drugs: advantages and problems.
    Rau JL
    Respir Care; 2005 Mar; 50(3):367-82. PubMed ID: 15737247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the human oropharyngeal airspaces using magnetic resonance imaging. III. The effects of device resistance with forced maneuver and tidal breathing on upper airway geometry.
    McRobbie DW; Pritchard SE
    J Aerosol Med; 2005; 18(3):325-36. PubMed ID: 16181007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between the oropharyngeal geometry and aerosols via pressurised metered dose inhalers.
    Ehtezazi T; Saleem I; Shrubb I; Allanson DR; Jenkinson ID; O'Callaghan C
    Pharm Res; 2010 Jan; 27(1):175-86. PubMed ID: 19902336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo-in vitro comparison of deposition in three mouth-throat models with Qvar and Turbuhaler inhalers.
    Zhang Y; Gilbertson K; Finlay WH
    J Aerosol Med; 2007; 20(3):227-35. PubMed ID: 17894531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the human oropharyngeal airspaces using magnetic resonance imaging. II. The use of three-dimensional gated MRI to determine the influence of mouthpiece diameter and resistance of inhalation devices on the oropharyngeal airspace geometry.
    Pritchard SE; McRobbie DW
    J Aerosol Med; 2004; 17(4):310-24. PubMed ID: 15684731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vibrating membrane devices deliver aerosols more efficient than standard devices: a study in a neonatal upper airway model.
    Tiemersma S; Minocchieri S; van Lingen RA; Nelle M; Devadason SG
    J Aerosol Med Pulm Drug Deliv; 2013 Oct; 26(5):280-6. PubMed ID: 23273244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.
    Walenga RL; Longest PW
    J Pharm Sci; 2016 Jan; 105(1):147-59. PubMed ID: 26852850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metered-dose inhalers, dry powder inhalers, and transitions.
    Fink JB
    Respir Care; 2000 Jun; 45(6):623-35. PubMed ID: 10894455
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Wei X; Hindle M; Kaviratna A; Huynh BK; Delvadia RR; Sandell D; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):358-371. PubMed ID: 29878859
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of the human oropharyngeal airspaces using magnetic resonance imaging. I. Validation of a three-dimensional MRI method for producing ex vivo virtual and physical casts of the oropharyngeal airways during inspiration.
    McRobbie DW; Pritchard S; Quest RA
    J Aerosol Med; 2003; 16(4):401-15. PubMed ID: 14977431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry powder aerosol delivery systems: current and future research directions.
    Chan HK
    J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro monodisperse aerosol deposition in a mouth and throat with six different inhalation devices.
    DeHaan WH; Finlay WH
    J Aerosol Med; 2001; 14(3):361-7. PubMed ID: 11693848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dry powder inhaler with reduced mouth-throat deposition.
    Wang ZL; Grgic B; Finlay WH
    J Aerosol Med; 2006; 19(2):168-74. PubMed ID: 16796541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Acoustic-Based Method to Detect and Quantify the Effect of Exhalation into a Dry Powder Inhaler.
    Holmes MS; Seheult JN; O'Connell P; D'Arcy S; Ehrhardt C; Healy AM; Costello RW; Reilly RB
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):247-53. PubMed ID: 25393346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oropharyngeal length in drug lung delivery via suspension pressurized metered dose inhalers.
    Ehtezazi T; Allanson DR; Jenkinson ID; O'Callaghan C
    Pharm Res; 2006 Jun; 23(6):1364-72. PubMed ID: 16715362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging inhalation aerosol devices and strategies: where are we headed?
    Zhou QT; Tang P; Leung SS; Chan JG; Chan HK
    Adv Drug Deliv Rev; 2014 Aug; 75():3-17. PubMed ID: 24732364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a general in vitro approach for prediction of total lung deposition in healthy adults for pharmaceutical inhalation products.
    Olsson B; Borgström L; Lundbäck H; Svensson M
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):355-69. PubMed ID: 23421897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Apparatus to Deliver Mannitol Powder for Bronchial Provocation in Children Under Six Years Old.
    Tang P; Leung SS; Hor E; Ruzycki CA; Carrigy NB; Finlay WH; Brannan JD; Devadason S; Anderson SD; Sly PD; Samnick K; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):452-61. PubMed ID: 25844950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.